Clinical translation of silica nanoparticles
Source abstract
Abstract
Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. Anselmo, A. C. & Mitragotri, S. Nanoparticles in the clinic: an update post COVID-19 vaccines. Bioeng. Transl Med. 6, e10246 (2021).
2. Yang, Y., Zhang, M., Song, H. & Yu, C. Silica-based nanoparticles for biomedical applications: from nanocarriers to biomodulators. Acc. Chem. Res. 53, 1545–1556 (2020).10.1021/acs.accounts.0c00280 ↗
3. Tan, A., Eskandar, N. G., Rao, S. & Prestidge, C. A. First in man bioavailability and tolerability studies of a silica–lipid hybrid (lipoceramic) formulation: a phase I study with ibuprofen. Drug Deliv. Transl Res. 4, 212–221 (2014).10.1007/s13346-013-0172-9 ↗
4. Bukara, K. et al. Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: proof of concept in man. Eur. J. Pharm. Biopharm. 108, 220–225 (2016).10.1016/j.ejpb.2016.08.020 ↗
5. Meola, T. R., Abuhelwa, A. Y., Joyce, P., Clifton, P. & Prestidge, C. A. A safety, tolerability, and pharmacokinetic study of a novel simvastatin silica-lipid hybrid formulation in healthy male participants. Drug Deliv. Transl Res. 11, 1261–1272 (2021).10.1007/s13346-020-00853-x ↗
6. Kharlamov, A. N. et al. Silica–gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale 7, 8003–8015 (2015).10.1039/C5NR01050K ↗
7. Kharlamov, A. N. et al. Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial. Future Cardiol. 13, 345–363 (2017).10.2217/fca-2017-0009 ↗
8. Rastinehad, A. R. et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc. Natl Acad. Sci. USA 116, 18590–18596 (2019).10.1073/pnas.1906929116 ↗
9. Zanoni, D. K. et al. Use of ultrasmall core-shell fluorescent silica nanoparticles for image-guided sentinel lymph node biopsy in head and neck melanoma. A nonrandomized clinical trial. JAMA Netw. Open 4, e211936 (2021).10.1001/jamanetworkopen.2021.1936 ↗
10. Phillips, E. et al. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci. Transl Med. 6, 260ra149 (2014).10.1126/scitranslmed.3009524 ↗